ContraFect Chairman Steven C. Gilman Returns from Temporary Medical Leave
May 30, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 30, 2017) - ContraFect Corporation (NASDAQ: CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics...
ContraFect Announces Second Quarter 2016 Results
August 09, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at Jefferies 2016 Healthcare Conference
June 01, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - June 01, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of...
Provista Diagnostics Announces Reelection of the Company's Board of Directors
September 21, 2015 14:04 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company developing and commercializing a new generation of proprietary blood-based...